Eerola H - Search Results

1

Hereditary breast cancer and handling of patients at risk.

Eerola H, Aittomäki K, Asko-Seljavaara S, Nevanlinna H, von Smitten K. Eerola H, et al. Scand J Surg. 2002;91(3):280-7. doi: 10.1177/145749690209100312. Scand J Surg. 2002. PMID: 12449472 Review.

2

No germline FH mutations in familial breast cancer patients.

Kiuru M, Lehtonen R, Eerola H, Aittomäki K, Blomqvist C, Nevanlinna H, Aaltonen LA, Launonen V. Kiuru M, et al. Among authors: eerola h. Eur J Hum Genet. 2005 Apr;13(4):506-9. doi: 10.1038/sj.ejhg.5201326. Eur J Hum Genet. 2005. PMID: 15523491

3

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.

Eerola H, Heikkilä P, Tamminen A, Aittomäki K, Blomqvist C, Nevanlinna H. Eerola H, et al. Breast Cancer Res. 2005;7(1):R93-100. doi: 10.1186/bcr953. Epub 2004 Nov 19. Breast Cancer Res. 2005. PMID: 15642173 Free PMC article.

4

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.

Eerola H, Heikkilä P, Tamminen A, Aittomäki K, Blomqvist C, Nevanlinna H. Eerola H, et al. Breast Cancer Res. 2005;7(4):R465-9. doi: 10.1186/bcr1025. Epub 2005 Apr 21. Breast Cancer Res. 2005. PMID: 15987451 Free PMC article.

5

BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.

Vahteristo P, Syrjäkoski K, Heikkinen T, Eerola H, Aittomäki K, von Smitten K, Holli K, Blomqvist C, Kallioniemi OP, Nevanlinna H. Vahteristo P, et al. Among authors: eerola h. Eur J Hum Genet. 2006 Feb;14(2):167-72. doi: 10.1038/sj.ejhg.5201542. Eur J Hum Genet. 2006. PMID: 16333312

6

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.

Eerola H, Heinonen M, Heikkilä P, Kilpivaara O, Tamminen A, Aittomäki K, Blomqvist C, Ristimäki A, Nevanlinna H. Eerola H, et al. Breast Cancer Res. 2008;10(1):R17. doi: 10.1186/bcr1863. Epub 2008 Feb 14. Breast Cancer Res. 2008. PMID: 18275599 Free PMC article.

7

Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.

Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H. Aaltonen K, et al. Among authors: eerola h. Clin Cancer Res. 2008 Apr 1;14(7):1976-83. doi: 10.1158/1078-0432.CCR-07-4100. Clin Cancer Res. 2008. PMID: 18381935

8

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.

Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H. Vahteristo P, et al. Among authors: eerola h. Br J Cancer. 2001 Mar 2;84(5):704-8. doi: 10.1054/bjoc.2000.1626. Br J Cancer. 2001. PMID: 11237395 Free PMC article.

9

Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland).

Eerola H, Pukkala E, Pyrhönen S, Blomqvist C, Sankila R, Nevanlinna H. Eerola H, et al. Cancer Causes Control. 2001 Oct;12(8):739-46. doi: 10.1023/a:1011272919982. Cancer Causes Control. 2001. PMID: 11562114

10

No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer.

Vahteristo P, Ojala S, Tamminen A, Tommiska J, Sammalkorpi H, Kiuru-Kuhlefelt S, Eerola H, Aaltonen LA, Aittomäki K, Nevanlinna H. Vahteristo P, et al. Among authors: eerola h. J Med Genet. 2005 Apr;42(4):e22. doi: 10.1136/jmg.2004.022327. J Med Genet. 2005. PMID: 15805151 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters